MedTrace Logo

Characteristics of Neonatal Covid-19 in Turkey

NCT04401540 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2020-07-14

No results posted yet for this study

Summary

The investigators aimed to investigate the clinical and epidemiological characteristics of neonates who will be born to Covid-19 positive mothers in Turkey. It is a multicentric prospective cohort study designed and destined only in Turkey. The investigators are planning to admit more than 20 Neonatal Intensive Care Units into the survey; nevertheless, the total number may change according to the prevalence of Covid-19 in neonates.

The investigators will also inquire into vertical transmission by collecting cord blood, placental, and postnatal serum samples to test for Covid-19 PCR and Covid-19 Ig M and IgG values from the neonates.

Conditions

Sponsors & Collaborators

  • Turkish Neonatal Society

    collaborator OTHER

  • Recep Tayyip Erdogan University Training and Research Hospital

    lead OTHER

Principal Investigators

  • Mehmet K Kanburoglu, M.D. · Head of Pediatrics and Neonatology, Associate Professor

Eligibility

Max Age
28 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-05-01
Primary Completion
2020-10-30
Completion
2020-12-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04401540 on ClinicalTrials.gov